These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road? Mwaba P; Chakaya JM; Petersen E; Wejse C; Zumla A; Kapata N Int J Infect Dis; 2020 Mar; 92S():S69-S71. PubMed ID: 32119979 [TBL] [Abstract][Full Text] [Related]
3. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation. Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068 [TBL] [Abstract][Full Text] [Related]
4. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]
5. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215 [TBL] [Abstract][Full Text] [Related]
6. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB). Zellweger JP; Sotgiu G; Corradi M; Durando P Med Lav; 2020 Jun; 111(3):170-183. PubMed ID: 32624559 [TBL] [Abstract][Full Text] [Related]
7. Algorithms for Screening for Active Tuberculosis among Individuals with Latent Tuberculosis Infection in a Rural Community in China. Xin H; Du Y; Cao X; Wang D; Zhang B; Zhang H; Feng B; He Y; He Y; Quan Z; Liu Z; Yan J; Guan L; Guan X; Shen F; Liu J; Jin Q; Pan S; Gao L Microbiol Spectr; 2022 Dec; 10(6):e0296722. PubMed ID: 36445141 [TBL] [Abstract][Full Text] [Related]
9. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia. Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595 [TBL] [Abstract][Full Text] [Related]
10. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents. So H; Yuen CS; Yip RM Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971 [TBL] [Abstract][Full Text] [Related]
11. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis. Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674 [TBL] [Abstract][Full Text] [Related]
12. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test. Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726 [TBL] [Abstract][Full Text] [Related]
13. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis. Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595 [TBL] [Abstract][Full Text] [Related]
14. The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda. Biraro IA; Kimuda S; Egesa M; Cose S; Webb EL; Joloba M; Smith SG; Elliott AM; Dockrell HM; Katamba A PLoS One; 2016; 11(1):e0146098. PubMed ID: 26771653 [TBL] [Abstract][Full Text] [Related]
15. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube. Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay]. Harada N Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047 [TBL] [Abstract][Full Text] [Related]
17. Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis. Kobashi Y; Shimizu H; Ohue Y; Mouri K; Obase Y; Miyashita N; Oka M Lung; 2010 Aug; 188(4):283-7. PubMed ID: 20422203 [TBL] [Abstract][Full Text] [Related]
18. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults. Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606 [TBL] [Abstract][Full Text] [Related]
19. Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays. Dirix V; Dauby N; Hites M; Watelet E; Van Praet A; Godefroid A; Petit E; Singh M; Locht C; Mascart F; Corbière V J Clin Microbiol; 2022 May; 60(5):e0244321. PubMed ID: 35430897 [TBL] [Abstract][Full Text] [Related]